Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CareCloud (CCLDO) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for CareCloud (CCLDO) over the last 13 years, with Q3 2025 value amounting to $174000.0.

  • CareCloud's Asset Writedowns and Impairment rose 807.45% to $174000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $393000.0, marking a year-over-year increase of 1260.74%. This contributed to the annual value of $334000.0 for FY2024, which is 2643.17% down from last year.
  • Latest data reveals that CareCloud reported Asset Writedowns and Impairment of $174000.0 as of Q3 2025, which was up 807.45% from $99000.0 recorded in Q2 2025.
  • CareCloud's Asset Writedowns and Impairment's 5-year high stood at $449000.0 during Q2 2022, with a 5-year trough of $25000.0 in Q4 2022.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $99000.0 (2025), whereas its average is $145315.8.
  • In the last 5 years, CareCloud's Asset Writedowns and Impairment skyrocketed by 179090.91% in 2021 and then plummeted by 9411.76% in 2022.
  • CareCloud's Asset Writedowns and Impairment (Quarter) stood at $425000.0 in 2021, then tumbled by 94.12% to $25000.0 in 2022, then skyrocketed by 160.0% to $65000.0 in 2023, then dropped by 23.08% to $50000.0 in 2024, then skyrocketed by 248.0% to $174000.0 in 2025.
  • Its last three reported values are $174000.0 in Q3 2025, $99000.0 for Q2 2025, and $70000.0 during Q1 2025.